Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect microneedle therapy showed encouraging results in treating basal cell carcinoma, ...

Medicus Pharma Ltd ( (MDCX) ) has shared an announcement.

Gordon Ramsay is one of the most popular chefs in the world. Along with his cooking finesse he is also a vocal health ...

Basal cell carcinoma has low immunogenicity. Tumor cells express Foxc1 protein (red), which suppresses HLA class I (green) in the tumor cells. Compromised antigen presentation ranks among the top ...

Medicus Pharma Ltd. MDCX shares surged to a high of $1.61 before falling during Thursday’s premarket session following the ...

Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ...

Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations in what skin cancer looks like can help ...

Add Yahoo as a preferred source to see more of our stories on Google. Skin cancer is the most common cancer in the U.S., according to the Centers for Disease Control and Prevention. Between 1982 and ...